table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 hospitalized
COVID-19 mild to moderate
non-steroidal anti-inflammatory drugs Guzman-Esquivel
Indomethacin Ravichandran

14 studies excluded by filtering options 1

5423 Jeong, 2020 1150not a RCTrisk of bias not avaialble
5477 Lund, 2020 1150not a RCTrisk of bias not avaialble
5764 Wenxin, 2020 1100not a RCTrisk of bias not avaialble
5902 Kragholm, 2020 2150excludednot a RCTrisk of bias not avaialble
5999 Rinott, 2020 1130not a RCTrisk of bias not avaialble
6028 Abu Esba LC (any NSAID use, acute and chronic), 2020 1100not a RCTrisk of bias not avaialble
6186 Gianfransesco, 2020 1110not a RCTrisk of bias not avaialble
6188 Bruce, 2020 1100not a RCTrisk of bias not avaialble
6189 Chandan, 2020 1150not a RCTrisk of bias not avaialble
6361 Ravichandran, 2020 1100not a RCTrisk of bias not avaialble
6960 Imam, 2020 1130not a RCTrisk of bias not avaialble
6994 Park, 2021 1120not a RCTrisk of bias not avaialble
7011 Drake, 2021 1100not a RCTrisk of bias not avaialble
7072 Kragholm, 2021 0130selection pending

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons